$INTS – Weekly Setup | High-Risk / High-Reward Swing Play
INTS remains heavily depressed after a long downtrend, but the recent weekly structure is starting to show signs of stabilization and potential accumulation.
This setup presents a very aggressive risk–reward, with substantial upside potential if price can hold above the recent support area.
📌 Entry
≈ 0.47 USD
📉 Stop-Loss
≈ 0.3445 USD
Below the most recent pivot — structure would be invalid if this level breaks.
🎯 Take-Profit (Main Target)
≈ 3.76 USD
Targeting prior imbalance + old liquidity zone around 3–4 USD.
📊 Risk / Reward
RR ≈ 1 : 6.8
Potential upside of over 680% if the target is reached.
📎 Technical Breakdown
Massive weekly selloff followed by compression and a strong impulse candle.
Potential CHoCH emerging.
Large liquidity pool above still untouched.
Highly speculative microcap setup; extremely volatile.
⚠️ Note
High-risk play. Valid only while price holds above 0.34 USD.
This setup presents a very aggressive risk–reward, with substantial upside potential if price can hold above the recent support area.
📌 Entry
≈ 0.47 USD
📉 Stop-Loss
≈ 0.3445 USD
Below the most recent pivot — structure would be invalid if this level breaks.
🎯 Take-Profit (Main Target)
≈ 3.76 USD
Targeting prior imbalance + old liquidity zone around 3–4 USD.
📊 Risk / Reward
RR ≈ 1 : 6.8
Potential upside of over 680% if the target is reached.
📎 Technical Breakdown
Massive weekly selloff followed by compression and a strong impulse candle.
Potential CHoCH emerging.
Large liquidity pool above still untouched.
Highly speculative microcap setup; extremely volatile.
⚠️ Note
High-risk play. Valid only while price holds above 0.34 USD.
Trade attivo
Profit of 7%, not bad. Let´s see what´s happening next week, this type of Pharma stocks can be violent.Nota
added some more here (100%) , total avg price $9.42 . Same TP´s.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.